What is the 13F Pro Quality Score for NHC?

13F Pro ranks NATIONAL HEALTHCARE CORP (NHC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NHC's current score at https://13fpro.ai/company/NHC (free sign-up required for the full ranking).

Where does 13F Pro source NHC data?

All NATIONAL HEALTHCARE CORP fundamentals and ownership data come directly from SEC EDGAR. NATIONAL HEALTHCARE CORP files with the SEC under CIK 1047335. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NHC in?

NATIONAL HEALTHCARE CORP (NHC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives NHC's revenue?

Per NATIONAL HEALTHCARE CORP's latest 10-Q filed with the SEC on 2026-08-06, the biggest revenue drivers are: Inpatient Services ($337.3M); Homecare and Hospice ($41.1M). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/NHC.

What are NHC's largest expenses?

NATIONAL HEALTHCARE CORP's latest 10-Q reports these as the largest expense items: Salaries, wages, and benefits ($241.9M, +6.8% YoY); Other operating ($94.5M, +2.8% YoY); Facility rent ($11.5M). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 30, 2026).

How often is NHC research updated on 13F Pro?

NHC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

NATIONAL HEALTHCARE CORP(NHC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 1047335 NHC stock profile & AI dashboard →

13F Pro Quality Score

65.9/100

Rank #452 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

72.4/100

Profitability

65.5/100

Balance Sheet

83.6/100

Earnings Quality

70.3/100

Free Cash Flow

54.3/100

Institutional Flow

21.1/100

Revenue Scale

58.8/100

Dilution Risk

82.6/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why NHC Scores 66/100

exact factor attribution · 2026-09-11

NHC's composite is driven by revenue growth and capital efficiency, held back by institutional flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+4.5 pts

72th pct

Capital efficiency

+3.4 pts

84th pct

Profitability

+2.3 pts

66th pct

Earnings quality

+2.0 pts

70th pct

Shareholder dilution

+1.6 pts

83th pct

Earnings growth

+1.6 pts

82th pct

Scale

+1.3 pts

59th pct

Free cash flow

+0.6 pts

54th pct

Institutional flow

-1.4 pts

21th pct

Latest change (2026-08-06): 71 → 67 · ↓ Revenue growth 76→59; ↓ Earnings growth 82→60

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

NHC Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for NATIONAL HEALTHCARE CORP (NHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NHC at 65.9/100 on a 32-signal composite quality model, placing it at rank #452 of 2,961 stocks — the top 25% of the AI-ranked universe. NHC scores in the top quartile across balance sheet strength (83.6). Areas of concern include institutional flow (21.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), NATIONAL HEALTHCARE CORP reports quarterly revenue of $408.0M, net income of $40.3M, an operating margin of 12.0%. Top institutional holders of NHC by reported 13-F value include BlackRock, Morgan Stanley Institutional Investment Advisors, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. NHC trades on the NYSE exchange and files with the SEC under CIK 1047335. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATIONAL HEALTHCARE CORP directly from SEC EDGAR. NATIONAL HEALTHCARE CORP's 13F Pro composite quality score has ranged between 33 and 71 since 2021, currently 65.9 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about NATIONAL HEALTHCARE CORP

Quirks, history, and lore behind NHC — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · small-cap · listed on NYSE American · headquartered in Tennessee.
2
The Numbers
Operates over 70 facilities across more than a dozen states, with annual revenue in the range of roughly $1 billion — steady, unglamorous, essential.
3
The History
Founded in 1971, it grew quietly through the post-Medicare boom era, building a network of long-term care and post-acute facilities across the American South and beyond.
4
The Secret
Its business lives at the intersection of skilled nursing, assisted living, and rehabilitation — the part of healthcare nobody thinks about until grandma needs it.
5
The Lore
Unusually for its size, it has paid dividends consistently for decades and is considered a rare independent operator in a sector dominated by giant chains and private equity roll-ups.
6
The Giveaway
Its three-letter ticker doubles as a shorthand for its full name, and its full name — National Healthcare Corp — is basically the plainest possible description of what it does.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving NHC's Business? Latest 10-Q Breakdown

✓ 29/29 datapoints verified

AI-extracted from NATIONAL HEALTHCARE CORP's 10-Q filed 2026-08-06 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

NHC's Q2 FY2026 net patient revenue rose 4.1% YoY to $378.4M on higher census (90.1% vs 89.4%) and per diem rates, while operating margin expanded to 12.0% from 9.1%, aided by a one-time $18.3M management-fee catch-up.

Biggest Revenue Drivers

Inpatient Services$337.3M

Driven by 90.1% average skilled nursing census (vs 89.4%) and a 1.5% higher composite per diem; includes $6.0M from the June 2026 acquisition of five SNFs from National Health Corporation.

Homecare and Hospice$41.1M

Net patient revenue from homecare and hospice agencies.

Biggest Revenue Drivers

Total revenue: $378.4M+4.1% YoY

Inpatient Services$337.3M

Driven by 90.1% average skilled nursing census (vs 89.4%) and a 1.5% higher composite per diem; includes $6.0M from the June 2026 acquisition of five SNFs from National Health Corporation.

Homecare and Hospice$41.1M

Net patient revenue from homecare and hospice agencies.

Largest Expense Items

Salaries, wages, and benefits$241.9M+6.8% YoY

Fell to 59.3% of net operating revenues from 60.4%; includes $3.7M added from newly acquired facilities.

Other operating$94.5M+2.8% YoY

Prior-year quarter included a $3.6M gain on land contributed to a joint venture that reduced the expense base; current quarter includes $1.5M from acquired facilities.

Facility rent$11.5M

Includes $9.99M paid under the NHI master lease, which was terminated after quarter-end upon NHC's $560M purchase of the leased facilities.

Margins: Total costs and expenses fell to 88.0% of net operating revenues from 90.9%, lifting operating margin to 12.0% from 9.1%, mainly due to a lower salaries/wages ratio (59.3% vs 60.4%) as revenue growth outpaced expense growth.

Watch Items from the Filing

The $190.4M marketable equity portfolio is 65.3% concentrated in National Health Investors (NHI) stock ($124.4M); a 10% price move would shift fair value by ~$19.0M.
Other revenues jumped 156.6% YoY partly from a one-time $18,325,000 management fee for pre-2025 services, recognized only now because revenue-recognition criteria were previously unmet; not indicative of run-rate performance.
Subsequent to quarter-end, NHC bought 32 SNFs and 3 ILFs from NHI for $560,000,000, funded by drawing $475,000,000 under a new term loan and $55,000,000 on a new revolver.
Self-insured accrued risk reserves for workers' compensation and professional liability total $121,129,000 amid an industry-wide rise in severity of long-term-care negligence claims.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$408.0M

Net Income

Q2 2026

$40.3M

Free Cash Flow

Q2 2026

$30.7M

Operating Margin

Q2 2026

12.0%

ROIC

Q2 2026

17.4%

D/E Ratio

Q2 2026

0.00

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+16.1% YoY

$1.52BFY 2025

FY22 $1.09BFY23 $1.14BFY24 $1.31BFY25 $1.52B

Net Income

+17.7% YoY

$120.0MFY 2025

FY22 $22.4MFY23 $66.8MFY24 $101.9MFY25 $120.0M

Operating Income

+49.7% YoY

$128.4MFY 2025

FY22 $31.9MFY23 $57.1MFY24 $85.8MFY25 $128.4M

EPS (Diluted)

+17.5% YoY

$7.67FY 2025

FY22 $1.45FY23 $4.34FY24 $6.53FY25 $7.67

Total Assets

+0.1% YoY

$1.53BFY 2025

FY22 $1.28BFY23 $1.31BFY24 $1.52BFY25 $1.53B

Total Debt

-67.1% YoY

$47.5MFY 2025

FY22 —FY23 $0.00FY24 $144.5MFY25 $47.5M

Op. Cash Flow

+72.5% YoY

$185.1MFY 2025

FY22 $8.7MFY23 $111.2MFY24 $107.3MFY25 $185.1M

Free Cash Flow

+86.5% YoY

$148.6MFY 2025

FY22 $-21.5MFY23 $83.3MFY24 $79.7MFY25 $148.6M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.52B +16.1%	$1.31B +14.5%	$1.14B +5.1%	$1.09B +1.1%	$1.07B +4.5%	$1.03B
Net Income	$120.0M +17.7%	$101.9M +52.6%	$66.8M +197.6%	$22.4M -83.8%	$138.6M +231.0%	$41.9M
Operating Income	$128.4M +49.7%	$85.8M +50.1%	$57.1M +79.1%	$31.9M -37.4%	$50.9M +5.8%	$48.2M
EPS (Diluted)	$7.67 +17.5%	$6.53 +50.5%	$4.34 +199.3%	$1.45 -83.9%	$8.99 +230.5%	$2.72
Total Assets	$1.53B +0.1%	$1.52B +16.3%	$1.31B +2.8%	$1.28B -9.1%	$1.40B +3.0%	$1.36B
Total Debt	$47.5M -67.1%	$144.5M	$0.00	—	—	$0.00
Operating Cash Flow	$185.1M +72.5%	$107.3M -3.5%	$111.2M +1172.2%	$8.7M -86.0%	$62.4M -69.3%	$203.3M
Free Cash Flow	$148.6M +86.5%	$79.7M -4.3%	$83.3M +488.3%	$-21.5M -193.3%	$23.0M -87.3%	$181.4M

Get alerted when NHC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NATIONAL HEALTHCARE CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NHC

BlackRock, Inc.
$417.6M1,975,785 sh
Morgan Stanley Institutional Investment Advisors LLC
$217.4M1,028,534 sh
DIMENSIONAL FUND ADVISORS LP
$196.5M929,692 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$171.0M809,224 sh
FIRST TRUST ADVISORS LP
$154.4M730,573 sh
VANGUARD CAPITAL MANAGEMENT LLC
$116.7M552,136 sh
STATE STREET CORP
$111.7M526,732 sh
GEODE CAPITAL MANAGEMENT, LLC
$80.5M380,934 sh
RENAISSANCE TECHNOLOGIES LLC
$63.3M299,717 sh
Invesco Ltd.
$37.0M175,290 sh

Fund	Value	Shares
BlackRock, Inc.	$417.6M	1,975,785
Morgan Stanley Institutional Investment Advisors LLC	$217.4M	1,028,534
DIMENSIONAL FUND ADVISORS LP	$196.5M	929,692
VANGUARD PORTFOLIO MANAGEMENT LLC	$171.0M	809,224
FIRST TRUST ADVISORS LP	$154.4M	730,573
VANGUARD CAPITAL MANAGEMENT LLC	$116.7M	552,136
STATE STREET CORP	$111.7M	526,732
GEODE CAPITAL MANAGEMENT, LLC	$80.5M	380,934
RENAISSANCE TECHNOLOGIES LLC	$63.3M	299,717
Invesco Ltd.	$37.0M	175,290

Companies Similar to NHC

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

ENSG

ENSIGN GROUP, INC

AI score

Similar quality profile · 10 shared holders

Hood River Capital Management LLC T. Rowe Price Investment Management, Inc.SEGALL BRYANT & HAMILL, LLC

IRMD

IRADIMED CORP

AI score

Similar quality profile · 12 shared holders

T. Rowe Price Investment Management, Inc.Bridge City Capital, LLC Susquehanna Portfolio Strategies, LLC

PACS

PACS Group, Inc.

AI score

Similar quality profile · 7 shared holders

T. Rowe Price Investment Management, Inc.Eversept Partners, LP ROYCE & ASSOCIATES LP

UTMD

UTAH MEDICAL PRODUCTS INC

AI score

Similar quality profile · 5 shared holders

SEGALL BRYANT & HAMILL, LLC Bridge City Capital, LLC MARTINGALE ASSET MANAGEMENT L P

SBC

SBC Medical Group Holdings Inc

AI score

Similar quality profile · 2 shared holders

SEGALL BRYANT & HAMILL, LLC Abel Hall, LLC

INVA

Innoviva, Inc.

AI score

Similar quality profile · 13 shared holders

SYSTEMATIC FINANCIAL MANAGEMENT LP MARTINGALE ASSET MANAGEMENT L P Susquehanna Portfolio Strategies, LLC

Pediatrix Medical Group, Inc.

AI score

Similar quality profile · 10 shared holders

CSM Advisors, LLC MARTINGALE ASSET MANAGEMENT L P Bridge City Capital, LLC

INFU

InfuSystem Holdings, Inc

AI score

Similar quality profile · 2 shared holders

OCCUDO QUANTITATIVE STRATEGIES LP Aster Capital Management (DIFC) Ltd

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put NHC on your watchlist

Track score changes the day NATIONAL HEALTHCARE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NHC a good stock to buy?

13F Pro's AI-powered analysis of NATIONAL HEALTHCARE CORP (NHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NHC are available on the NHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NHC is classified as a mid company.

Which hedge funds own NHC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NATIONAL HEALTHCARE CORP's investment landscape.